NasdaqGS - Nasdaq Real Time Price USD
Repare Therapeutics Inc. (RPTX)
1.3550
-0.0050
(-0.37%)
As of 2:41:02 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.65 | -0.56 | -2.11 | 0 |
| Low Estimate | -0.65 | -0.56 | -2.11 | 0 |
| High Estimate | -0.65 | -0.56 | -2.11 | 0 |
| Year Ago EPS | 0.3 | -0.82 | -1.96 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | 1.67M | 1.67M | 6.67M | 10M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 5M | 5M | 20M | 20M |
| Year Ago Sales | 52.4M | 1.07M | 53.48M | 6.67M |
| Sales Growth (year/est) | -96.82% | 55.33% | -87.53% | 50.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.87 | -0.86 | -0.79 |
| EPS Actual | 0.3 | -0.82 | -0.77 | -0.68 |
| Difference | 0.39 | 0.05 | 0.09 | 0.12 |
| Surprise % | 440.91% | 5.53% | 10.20% | 14.55% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.65 | -0.56 | -2.11 | 0 |
| 7 Days Ago | -0.58 | -0.47 | -1.38 | 0 |
| 30 Days Ago | -0.62 | -0.53 | -1.73 | 0 |
| 60 Days Ago | -0.72 | -0.66 | -2.52 | 0 |
| 90 Days Ago | -0.71 | -0.65 | -2.84 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | -- |
| Up Last 30 Days | 2 | 2 | 2 | -- |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RPTX | -316.67% | 31.71% | -7.42% | -- |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Downgrade | LifeSci Capital: Outperform to Market Perform | 12/13/2024 |
| Maintains | Stifel: Buy to Buy | 12/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/24/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/23/2024 |
Related Tickers
HLVX HilleVax, Inc.
1.9050
-0.26%
ANTX AN2 Therapeutics, Inc.
1.1750
-3.69%
EPIX ESSA Pharma Inc.
1.7100
0.00%
KROS Keros Therapeutics, Inc.
13.78
-1.71%
IPSC Century Therapeutics, Inc.
0.5298
+1.88%
SPRO Spero Therapeutics, Inc.
0.6399
+11.29%
KZR Kezar Life Sciences, Inc.
4.2500
+3.16%
ASMB Assembly Biosciences, Inc.
12.30
+5.45%
PMVP PMV Pharmaceuticals, Inc.
0.8950
+1.27%
CLRB Cellectar Biosciences, Inc.
0.2484
-1.23%